Libera Bio
About:
Addressing “undruggable intracellular targets” in oncology
Website: http://www.liberabio.com/
Twitter/X: bio_libera
Top Investors: Inaki Berenguer, Xesgalicia, The EmprendeXXI Awards, Innova-Tech Consulting
Description:
Libera Bio aims at changing cancer therapy by allowing biologics to cross the cell membrane and reach “undruggable” intracellular targets: the “Holy Grail” in oncology
Total Funding Amount:
1.3M EUR
Headquarters Location:
Santiago De Compostela, Galicia, Spain
Founded Date:
2020-01-01
Contact Email:
Contact(AT)LiberaBio.com
Founders:
Desirée Teijeiro Osorio, Olivier Jarry
Number of Employees:
11-50
Last Funding Date:
2023-04-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai